Macphar Remedies

Macphar Caring for Life: What started as one man’s journey and his belief in the virtue of his cause, has paved the path for MACPHAR to become a pharmaceutical major. MACPHAR began as one man’s dream of creating a better world. Shri Uttam Kumar Jain , believed in the idea of ‘simple living and high thinking’ and aspired to put India on the global pharmaceuticals map. His legacy is one of performance, values and public spiritedness. When Mr. Jain started in 1972, Started a small wholesale distribution shop in Jaipur. Business to him was sacred and he operated with the highest ethical standards, professionalism and respect.Over the past 50 years, with Mr Jain at the helm of affairs, he saw both struggles and victories. But his personality encouraged learning from the experiences and never rest on laurels. He inspired his both son’s to move ahead, set high targets and meet one’s goals through unyielding commitment to compliance and integrity. He had a compelling vision of the future and strived to light the path of glory. Today, we are truly a pharmaceutical company focused on meaningful and differentiated product portfolio comprising of Complex Generics, Biosimilars and Specialty Products. As we continue the journey started in 1972, we commit to the legacy that is our honour to uphold.

Novus Life Sciences Pvt. Ltd.

Novus Life Sciences Pvt. Ltd. is a leading pharmaceutical company in India engaged in Manufacturing, Marketing and Exporting pharmaceutical formulations for the past 36 years. Novus specializes in manufacturing a wide range of formulations including Tablets, Capsules, Soft gelatin Capsules, Syrups, Dry Syrups, Injections (both dry powder and small volume), Eye/Ear Drops and Ointments. Our products range from various therapeutic segments like Cardio-vascular, Anti-Diabetic, Anti-Malarials, Anti-Tubercular, Neuropsychiatry, Antibiotics and Nutritional Supplements.

Infugen Pharma Pvt Ltd

Infugen is the fastest growing Export House in healthcare sector focusing mainly on Pharma formulations. Infugen is single point solution provider for its Global partners, having presence in Mozambique, Angola, Rwanda, Uganda, Tanzania, Senegal, Tajikistan, Lesotho, Zambia, Kenya, Ethiopia, Eritrea, Trinidad & Tobago, Mongolia, Cambodia, Vietnam, Sri Lanka & Myanmar. Infugen has diversified product portfolio from formulations to Medical / Surgical Devices & Disposables, Diagnostic Kits, Ortho Implants, Ophthalmic lens and equipment as well as Cardiology Stents. We are associated with WHO GMP certified Units for Pharma Formulations which are dedicated facilities in respective segment and ISO/ CE certified Units for Devices, Disposables and Diagnostics. We are strategic partner to overseas customers for local government tenders. We have successfully supplied in government tenders of CMAM (Mozambique), RBC (Rwanda), NIPDEC (Trinidad & Tobago), NDSO (Lesotho) providing value added business to our partners. Also we are associated with WHO Pre-Qualified unit for Contraceptives which is pre-requisite in WHO funded population control tenders. We are now looking to expand our reach in Rest of Africa as well as Latin & Central America, CIS region where we can offer effective healthcare solutions. We are also nurturing talent , where we are building a team , If anyone looking to make a career in International Market , they can mail their CV to hr@infugenpharma.com

usv private limited

USV is a 62 year young Indian healthcare company with pharmaceutical manufacturing & research and marketing capabilities for Pharma & Consumer business. The company started as a subsidiary of Revlon and now operates as an independent entity in domestic and international markets. Built on deeply rooted Credo values, the company is leading in therapeutic segments like Cardio and Diabetology in India. It is also significant in Vitamins, Minerals, Nutrients, Dermatology, Gastroenterology and CNS. USV’s International business consists of a portfolio of small molecule APIs (31 of which are commercially available) and finished dosages exported to 65+ countries. It has 7 manufacturing plants across India (4 for Formulation, 2 for APIs & 1 for Biological Drugs), a Corporate office and a Research & Development Center in Mumbai with the help of 6800+ human capital. The facilities are accredited by global regulators such as USFDA, EMA, MHRA & others and are cGMP compliant. USV’s promise of being a reliable health partner to its customers and stakeholders is reflected in its leadership position in the Oral Anti-Diabetic market - ranked #1 by Rx and Value and in the Cardiovascular diseases segment - ranked #1 by Rx and #4 by Value. The company invests 3% of its revenue in R&D and has received a grant for 12 patents. USV’s Consumer Business: Sebamed is a leading Baby and Personal care brand. Other segments include Beauty, Food, and nutrition. It ranks #3 in Indian Baby care and is growing exponentially. USV lives by the culture of excellence through quality products, therapy leadership, a robust supply chain and sustainable practices & giving back to society. USV Credos: Customer Orientation, Collaboration, Commitment, Challenge, Communication, and Cheerfulness are guiding forces in how it operates.

Wockhardt Ltd.

Wockhardt is a global pharmaceutical and biotechnology organization, providing affordable, high-quality medicines for a healthier world. It is India’s leading research-based global healthcare enterprise with relevance in the fields of Pharmaceuticals, Biotechnology and a chain of advanced Super Specialty Hospitals. Wockhardt is a true Indian Multi-National Company with a multi-ethnic workforce of 3000 Wockhardt Associates from 21 different nationalities globally. It has 3 research centers and 12 manufacturing plants, with businesses ranging from the manufacture and marketing of Pharmaceutical and Bio-pharmaceutical formulations, Active Pharmaceutical Ingredients (APIs) and Vaccines. Headquartered in Mumbai, India, Wockhardt has full-fledged operations in the USA, UK, Ireland and France. It also has its marketing presence in emerging markets of Russia, Brazil, Mexico, Vietnam, Philippines, Nigeria, Kenya, Ghana, Tanzania, Uganda, Nepal, Myanmar, Sri Lanka, Mauritius, Lebanon and Kuwait. Wockhardt’s core business is innovation. It uses science and technology to develop medicines and other products that improve the quality of millions people’s lives through better health. Wockhardt aspires to create a healthier world. Its strategic vision of ‘More & More with Less & Less’ has transformed into new ways of thinking, a new journey for growth, medical breakthroughs for patients and continuing value for all stakeholders.